Sjogren's syndrome-associated meningoencephalomyelitis: Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus

Journal of the Neurological Sciences

Volumn 267, Issue 1-2, 2008, Pages 182-186

  Hoshina, Takayuki ^a   Yamaguchi, Yui ^a   Ohga, Shouichi ^a   Kira, Ryutaro ^a   Ishimura, Masataka ^a   Takada, Hidetoshi ^a   Tanaka, Tamami ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytokine profile; Encephalomyelitis; Interleukin 6; Meningoencephalitis; Sjogren's syndrome; Tacrolimus therapy

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONSCIOUSNESS; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; ENCEPHALOMYELITIS; FEMALE; HUMAN; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHYSICAL EXAMINATION; PLEOCYTOSIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SLOW BRAIN WAVE; URINE RETENTION;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BRAIN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MENINGOENCEPHALITIS; METHYLPREDNISOLONE; MONITORING, PHYSIOLOGIC; MYELITIS; PREDICTIVE VALUE OF TESTS; SJOGREN'S SYNDROME; SPINAL CORD; TACROLIMUS; TREATMENT OUTCOME; VOMITING;

EID: 39049146972     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.10.009     Document Type: Article

References (31)

1. Moutsopoulos H.M. Sjogren's syndrome. In: Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. 15th ed. (2001), McGraw-Hill, New York 1947-1949
2. Alexander E.L., Provost T.T., Stevens M.B., and Alexander G.E. Neurologic complications of primary Sjogren's syndrome. Medicine 61 (1982) 247-257
3. De Backer H., and Dehaene I. Central nervous system disease in primary Sjogren's syndrome. Acta Neurol Belg 95 (1995) 142-146
4. Manabe Y., Sasaki C., Warita H., Hayashi T., Shiro Y., Sakai K., et al. Sjogren's syndrome with acute transverse myelopathy as the initial manifestation. J Neurol Sci 176 (2000) 158-161
5. Binder A., Snaith M.L., and Isenberg D. Sjogren's syndrome: a study of its neurological complications. Br J Rheumatol 27 (1988) 275-280
6. Vincent T.L., Richardson M.P., Mackworth-Young C.G., Hawke S.H., and Venables P.J.W. Sjogren's syndrome-associated myelopathy: response to immunosuppressive treatment. Am J Med 114 (2003) 145-148
7. Alexander E.L., and Alexander G.E. Aseptic meningoencephalitis in primary Sjogren's syndrome. Neurology 33 (1983) 593-598
8. Vrethem M., Ernerudh J., Lindstrom F., and Skogh T. Immunoglobulins within the central nervous system in primary Sjogren's syndrome. J Neurol Sci 100 (1990) 98-107
9. Sharief M.K., and Thompson E.J. Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry 52 (1989) 949-953
10. Alexander E.L. Neurologic disease in Sjogern's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. Rheum Dis Clin North Am 19 (1993) 869-908
11. Griffin J.W., Cornblath D.R., Alexander E., Campbell J., Low P.A., Bird S., et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol 27 (1990) 304-315
12. Pflugfelder S.C., Jones D., Ji Z., Afonso A., and Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 19 (1999) 201-211
13. Cuello C., Palladinetti P., Tedla N., DI Girolamo N., Lloyd A.R., McCluskey P.J., et al. Chemokine expression and leucocyte infiltration in Sjogren's syndrome. Br J Rheumatol 37 (1998) 779-783
14. Szodoray P., Alex P., Brun J.G., Centola M., and Jonsson R. Circulating cytokines in primary Sjogern's syndrome determined by a multiplex cytokine array system. Scand J Immunol 59 (2004) 592-599
15. Ohga S., Aoki T., Okada K., Akeda H., Fujioka K., Ohshima A., et al. Cerebrospinal fluid concentrations of interleukin-1β, tumor necrosis factor-α, and interferon gamma in bacterial meningitis. Arch Dis Child 70 (1994) 123-125
16. Minamishima I., Ohga S., Ishii E., Miyazaki C., Hamada K., Akazawa K., et al. Aseptic meningitis in children: correlation between fever and interferon-gamma level. Eur J Pediatr 150 (1991) 722-725
17. Nishida H., Tanaka Y., Yasuda S., and Yamada M. A case of primary Sjogren's syndrome presenting with aseptic meningoencephalitis associated with sarcoidosis. No To Shinkei 51 (1999) 349-352
18. Trysberg E., Carlsten H., and Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9 (2000) 498-503
19. Kaplin A.I., Deshpande D.M., Scott E., Krishnan C., Carmen J.S., Shats I., et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115 (2005) 2731-2741
20. Dulkerian S.J., Kilpatrick L., Costarino A.T., McCawley L., Fein J., Corcoran L., et al. Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 126 (1995) 872-876
21. Rogers S.J., Williams C.S., and Roman G.C. Myelopathy in Sjogren's syndrome: role of nonsteroidal immunosuppressants. Drugs 64 (2004) 123-132
22. Menage P., de Toffol B., Degenne D., Saudeau D., Bardos P., and Autret A. Gougerot-Sjogren syndrome. Central neurological involvement with recurrent development. Rev Neurol 149 (1993) 554-556
23. Wright R.A., O'Duffy J.D., and Rodriguez M. Improvement of myelopathy in Sjogren's syndrome with chlorambucil and prednisone therapy. Neurology 52 (1999) 386-388
24. Williams C.S., Butler E., and Roman G.C. Treatment of myelopathy in Sjogren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 58 (2001) 815-819
25. Hermisson M., Klein R., Schmidt F., Weller M., and Kuler W. Myelopathy in primary Sjogren's syndrome: diagnostic and therapeutic aspects. Acta Neurol Scand 105 (2002) 450-453
26. Hawley R.J., and Hendricks W.T. Treatment of Sjogren syndrome myelopathy with azathioprine and steroids. Arch Neurol 59 (2002) 875
27. Tristano A.G. A case of Sjogren's syndrome with acute transverse myelitis and polyneuropathy in a patient free of sicca symptoms. Clin Rheumatol 25 (2005) 113-114
28. Quartuccio L., Ferraccioli G.F., and De Vita S. Transverse myelitis in primary Sjogren's syndrome: usefulness of low-dose oral cyclophosphamide rather than pulse therapy. Scand J Rheumatol 35 (2006) 409-410
29. Yamout B., El-Hajj T., Barada W., and Uthman I. Successful treatment of refractory neuroSjogren with rituximab. Lupus 16 (2007) 521-523
30. Gold B.G., Voda J., Yu X., Mckeon G., and Bourdette D.N. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. J Neurosci Res 77 (2004) 367-377
31. cg gene and the therapeutic efficacy of an immunosuppressive agent FK506. Pathol Int 49 (1999) 133-140